Vakrangee Ltd (BOM:511431)

₹ 23.94 -0.55 (-2.25%) Market Cap: 25.77 Bil Enterprise Value: 25.21 Bil PE Ratio: 598.50 PB Ratio: 15.65 GF Score: 57/100

Q1 2024 Vakrangee Limited Earnings Call Transcript
Jul 17, 2023

₹16.38 (-1.74%)

Earnings
Q4 2023 Vakrangee Limited Earnings Call Transcript
May 30, 2023

₹16.08 (-0.80%)

Earnings
Q3 2023 Vakrangee Limited Earnings Call Transcript
Feb 03, 2023

₹24.32 (-2.43%)

Earnings
Q2 2023 Vakrangee Limited Earnings Call Transcript
Oct 21, 2022

₹30.47 (-0.91%)

Earnings
Q1 2023 Vakrangee Limited Earnings Call Transcript
Jul 07, 2022

₹25.67 (+1.29%)

Earnings
Q4 2022 Vakrangee Limited Earnings Call Transcript
May 16, 2022

₹29.63 (+0.32%)

Earnings
Q3 2022 Vakrangee Ltd Earnings Call Transcript
Jan 24, 2022

₹36.06 (-4.80%)

Earnings
Q2 2022 Vakrangee Ltd Earnings Call Transcript
Oct 12, 2021

₹40.63 (-0.91%)

Earnings
Q1 2022 Vakrangee Ltd Earnings Call Transcript
Jul 26, 2021

₹34.66 (-0.53%)

Earnings
Q4 2021 Vakrangee Ltd Earnings Call Transcript
Jun 21, 2021

₹43.37 (-2.82%)

Earnings
Q3 2021 Vakrangee Ltd Earnings Call Transcript
Feb 08, 2021

₹49.99 (-1.47%)

Earnings
Q2 2021 Vakrangee Ltd Earnings Call Transcript
Oct 30, 2020

₹26.32 (-1.57%)

Earnings
Q4 2020 Vakrangee Ltd Earnings Call Transcript
Jul 31, 2020

₹26.37 (-1.05%)

Earnings
Q3 2020 Vakrangee Ltd Earnings Call Transcript
Feb 13, 2020

₹42.12 (+4.51%)

Earnings
Q2 2020 Vakrangee Ltd Earnings Call Transcript
Nov 13, 2019

₹36.9 (-0.63%)

Earnings
Q1 2020 Vakrangee Ltd Earnings Call Transcript
Aug 13, 2019

₹33.27 (+0.42%)

Earnings
Q4 2019 Vakrangee Ltd Earnings Call Transcript
May 13, 2019

Earnings

Q2 2021 Vakrangee Ltd Earnings Call Transcript

Oct 30, 2020 / 11:30AM GMT

Release Date Price: ₹26.32 (-1.57%)

Transcript

Dinesh Nandwana

Vakrangee Limited - MD, Group CEO & Executive Director

Good day, ladies and gentlemen. It is pleasure to greet you all once again on behalf of our Board of Directors and senior management. We'll begin by thanking all of you for having spare time in joining us here today to discuss our second quarter earnings for the financial year 2021.

As with respect to our business strategy, we believe that the worst is behind us, and we shall be showcasing better growth and improved financials every quarter-on-quarter basis. Revenue had been materially impacted on year-on-year basis due to COVID-19 pandemic and nationwide lockdown situation. The company's return to normalcy on the business front has been progressing well with month-on-month improvement in sales. However, normalization shall take a couple of quarters.

Outlet revenue has been impacted as only our key essential services like banking, ATM, mobile recharge and telemedicine services have been operational. However, other key services like assisted online shopping, online pharmacy, travel services and logistics have

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.